H1

AstraZeneca is celebrating positive Phase 3 study results from earlier this week. Eneboparatide met its primary endpoint in the treatment of adults with chronic hypoparathyroidism compared to placebo at 24 weeks. Since patients with hypoparathyroidism are often at risk for calcium-related conditions like osteoporosis, this new treatment could offer them a new option in place of other therapies. https://hubs.la/Q03cLP1M0 #eneboparatide #hypoparathyroidism

As a startup health plan, Taro Health needed a data technology partner to build their provider data infrastructure from the ground up. They needed to power their “Find Care” tool to help their members find dedicated Primary Care Physicians as part of their Direct Primary Care model. See how H1 created an end-to end provider data management infrastructure to transform and enrich Taro’s existing network data into accurate, complete data that powers a positive provider search experience. Learn more: https://hubs.la/Q03cHFMR0 #providerdata #findcare #tarohealth #directprimarycare #networkdata

Is your medical affairs team able to build out data-driven business cases that prove the value of the team’s efforts? Find out how Katie Shin accomplished this by using H1 data to forge a path for Sumitomo Pharma America, Inc.’s field medical execution. https://hubs.la/Q03cnTqc0 Learn more about our solutions for medical teams: https://hubs.la/Q03cp4G20

If you're attending MAPS Americas later this week, the H1 team would love to speak with you! Our solutions empower #MSLs to surface the right #KOLs and measure the impact of KOL engagements. You can find us in Booth 207 for a demo of our medical solutions and to get answers to any questions you might have. See you there! https://hubs.la/Q03c3qj60 #MAPS #MAPSAmericas #medicalaffairs

Maintaining accurate provider data is a constant challenge for health plans. Provider information, including contact details and network affiliations, is constantly changing, making accurate data a moving and expensive target. Did you know that only 38% trust their health plan to find a provider that's right for them? Download The State of Provider Data Accuracy Report to see the current state of provider data accuracy and explore better ways to maintain accurate provider information. Download here: https://hubs.la/Q03c6ldM0 #providerdata #providerdataaccuracy #industryreport

Gilead Sciences alongside GSK and ViiV Healthcare are moving forward with #HIV options in development. After strong Phase I studies showing that twice-yearly lenacapavir could prevent HIV in the vast majority of participants, Gilead is moving straight to Phase III, which will look at once-yearly treatments for pre-exposure prophylaxis (PrEP) use. GSK & ViiV’s long-acting antiviral VH499 achieved a strong reduction in viral load while also being well-tolerated. All strong advancements for HIV treatment and prevention! https://hubs.la/Q03bQ2pW0

Didn’t make it to the 2025 American Academy of Dermatology (AAD) Annual Meeting this week? You may have missed out on valuable KOL meeting opportunities. Below, we’re sharing just a handful of the insights that H1 offers to help your MSL team make the most of the 2025 conference season. Find out which KOLs are attending which conferences so you can plan effectively. See the depth of information that H1’s HCP Universe offers: https://hubs.la/Q03bypbz0 Get a more comprehensive look by requesting a demo: https://hubs.la/Q03byd3n0

In case you missed it, we recently published a blog post to share the ways we've helped Johnson & Johnson surface previously unknown KOLs. Jennifer Wheeler, Immunology Medical Affairs Analytics at J&J has been able to boost her engagement strategies, strengthen advisory boards, and more with H1 insights. Learn more about her story by reading the blog: https://hubs.la/Q03bcjzK0 #kol #kolengagement #hcpengagement #healthcaredata

MAPS Americas is right around the corner. Will you be attending this year? The H1 team will be there to show you how we empower #MSLs to surface the right #KOLs and to measure the impact of their engagements. Saving time finding and tracking #HCPs, and book more meetings with H1 for Medical solutions. Come see us in Booth 207 for a demo of our medical solutions. We’re happy to answer any question you have! https://hubs.la/Q03b96Qy0 #MAPS #MAPSAmericas #medicalaffairs

At Johnson & Johnson, #healthequity is a part of everything they do, whether it’s identifying care gaps on the medical side or underrepresented patients on the clinical side. According to Jennifer Wheeler, Associate Director of Analytics at J&J: “We want to make sure that all patients are getting the care that they need and making sure that our products are representative of all the patients out there that could possibly use them.” With H1’s comprehensive race and ethnicity data on both HCPs and patients, Jennifer has gained clarity on regional population breakdowns that inform her overall strategy. Watch the interview to learn more: https://hubs.la/Q038LqKk0